Selective testing of women based on age for genital Chlamydia trachomatis and Neisseria gonorrhoeae infection in a centralized regional microbiology laboratory

Diagnostic Microbiology and Infectious Disease

Volumn 57, Issue 4, 2007, Pages 379-385

  Church, Deirdre L ^a,b,c   Amante, L ^a   Semeniuk, H ^a   Gregson, D B ^a,b,c  

^a CALGARY LABORATORY SERVICES   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Age; Chlamydia trachomatis; Neisseria gonorrhoeae

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CANADA; CHLAMYDIA TRACHOMATIS; CLINICAL PRACTICE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; GENITAL TRACT INFECTION; HEALTH CARE COST; HUMAN; INCIDENCE; LABORATORY TEST; MICROBIOLOGY; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; TURNAROUND TIME;

ADOLESCENT; ADULT; AGE FACTORS; ALBERTA; CHILD; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HUMANS; LABORATORIES; MICROBIOLOGY; MIDDLE AGED; NEISSERIA GONORRHOEAE; REGIONAL MEDICAL PROGRAMS; RISK ASSESSMENT; VAGINAL SMEARS;

EID: 33947693361     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.10.009     Document Type: Article

References (25)

1. Alberta Health and Wellness. Sexually Transmitted Diseases in Alberta. Epidemiologic Report to December 1997 (1998) Health Surveillance Branch, Alberta Health and Wellness, Edmonton, Alberta, Ref Type: Report.
2. Canada Communicable Disease Report (CCDR) (2005) 2002 Canadian Sexually Transmitted Infections Surveillance Report (Supplement). June [31S2], 1-49, Public Health Agency of Canada, Ottawa, Ont. Ref Type: Serial (Book, Monograph).
3. Canadian STD Guidelines (1998) Laboratory Centre for Disease Control Expert Working Group on Canadian Guidelines for Sexually Transmitted Diseases. Ottawa, Ontario, Minister of Public Works and Government Service Canada. Ref Type: Report.
4. Carroll K.C., Aldeen W.E., Morrison M., Anderson R., Lee D., and Mottice S. Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population. J. Clin. Microbiol. 36 (1998) 1630-1633
5. Cates Jr. W., and Wasserheit J.N. Genital chlamydial infections: epidemiology and reproductive sequelae. Am. J. Obstet. Gynecol. 164 (1991) 1771-1781
6. Centers for Disease Control and Prevention (CDC) (2002). Screening Tests to Detect Chlamydia trachomatis and Neisseria gonorrhoeae Infections-2002. RR-15, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Ref Type: Report.
7. Church, D.L., (2002). Epidemiology of genital Chlamydia trachomatis (CT) infection in women in the Calgary Health Region (CHR): who should be tested? Microbiology Newsletter 9[Sept.], 1-2, Calgary Laboratory Services (CLS). Ref Type: Electronic Citation.
8. Church D.L., and Hall P. Centralization of a regional clinical microbiology service: the Calgary experience. Can. J. Infect Dis. 10 (1999) 393-402
9. Church D.L., Zentner A., Semeniuk H., Henderson E., and Read R. Reasons for testing women for genital Chlamydia trachomatis infection in the Calgary region. Can. J. Infect. Dis. 14 (2003) 35-40 Ref Type: Journal (Full)
10. Creighton S., Tenant-Flowers M., Taylor C.B., Miller R., and Low N. Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean?. Int. J. STD AIDS 14 (2003) 109-113
11. Ford C.A., Pence B.W., Miller W.C., Resnick M.D., Bearinger L.H., Pettingell S., and Cohen M. Predicting adolescents' longitudinal risk for sexually transmitted infection: results from the National Longitudinal Study of Adolescent Health. Arch. Pediatr. Adolesc. Med. 159 (2005) 657-664
12. Honey E., Augood C., Templeton A., Russell I., Paavonen J., Mardh P.A., Stary A., and Stray-Pedersen B. Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies. Sex. Transm. Infect. 78 (2002) 406-412
13. Howell M.R., Quinn T.C., and Gaydos C.A. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann. Intern. Med. 128 (1998) 277-284
14. Marrazzo J.M., Fine D., Celum C.L., DeLisle S., and Handsfield H.H. Selective screening for chlamydial infection in women: a comparison of three sets of criteria. Fam. Plann. Perspect. 29 (1997) 158-162
15. Miller W.C. Screening for chlamydial infection: are we doing enough?. Lancet 365 (2005) 456-458
16. Miller W.C., Ford C.A., Morris M., Handcock M.S., Schmitz J.L., Hobbs M.M., Cohen M.S., Harris K.M., and Udry J.R. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 291 (2004) 2229-2236
17. Miller W.C., Hoffman I.F., Owen-O'Dowd J., McPherson J.T., Privette A., Schmitz J.L., Woodlief G., and Leone P.A. Selective screening for chlamydial infection: which criteria to use?. Am. J. Prev. Med. 18 (2000) 115-122
18. Moller J.K., Andersen B., Olesen F., and Ostergaard L. Reasons for Chlamydia trachomatis testing and the associated age-specific prevalences. Scand. J. Clin. Lab. Invest. 63 (2003) 339-345
19. Peeling R., and King L. Sexually transmitted diseases: impact of molecular laboratory diagnostic methods on disease control and prevention. Can. J. Infect. Dis. 10 (1999) 309-387
20. Rothenberg R.B., Wasserheit J.N., St Louis M.E., and Douglas J.M. The effect of treating sexually transmitted diseases on the transmission of HIV in dually infected persons: a clinic-based estimate. Ad Hoc STD/HIV Transmission Group. Sex. Transm. Dis. 27 (2000) 411-416
21. Semeniuk H., Zentner A., Read R., and Church D. Evaluation of sequential testing strategies using non-amplified and amplified methods for detection of Chlamydia trachomatis in endocervical and urine specimens from women. Diagn. Microbiol. Infect. Dis. 42 (2002) 43-51
22. Wasserheit J.N. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex. Transm. Dis. 19 (1992) 61-77
23. Weyman K., and Lanning A.R. Screening guidelines for Chlamydia trachomatis infection. Evaluating physician awareness, agreement, and use. Can. Fam. Physician 41 (1995) 228-236
24. Wiesenfeld H.C., Dennard-Hall K., Cook R.L., Ashton M., Zamborsky T., and Krohn M.A. Knowledge about sexually transmitted diseases in women among primary care physicians. Sex. Transm. Dis. 32 (2005) 649-653
25. Workowski K.A., Levine W.C., and Wasserheit J.N. US Centers for Disease Control and Prevention guidelines for the treatment of sexually transmitted diseases: an opportunity to unify clinical and public health practice. Ann. Intern. Med. 137 (2002) 255-262